GV
Venture capital
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
20Deep-tech portfolio11 active
9Portfolio exitsAcquired or listed
2Raises, 12 monthsLatest: Stipple Bio
81Co-investorsShare a portfolio company
Portfolio · 20 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Stipple Bio | Biotech | Active | Apr 6, 2026 | $86.6M |
| Pelage Pharmaceuticals | Biotech | Active | Nov 24, 2025 | $150.7M |
| Dandelion Energy | Clean tech | Active | Nov 18, 2022 | $133.8M |
| Lyell Immunopharma | Biotech | Active | Mar 20, 2020 | $493.0M |
| Calico | Biotech | Active | — | — |
| Cellarity | Biotech | Active | — | — |
| Foresite Labs | Biotech | Active | — | — |
| Gate Bioscience | Biotech | Active | — | — |
| Isomorphic Labs | Biotech | Active | — | — |
| Sandbox AQ | Quantum | Active | — | — |
| Syremis Therapeutics | Biotech | Active | — | — |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Nuvation Bio | Biotech | Public | Oct 20, 2020 | $275.3M |
| iTeos Therapeutics | Biotech | Acquired | Apr 9, 2020 | $125.4M |
| Passage Bio | Biotech | Public | Sep 6, 2019 | $110.0M |
| Freenome | Medtech | Public | Oct 28, 2015 | $800K |
| DeepMind | Biotech | Acquired | — | — |
| Prime Medicine | Biotech | Public | — | — |
| Tempus AI | Medtech | Public | — | — |
| Verily Life Sciences | Digital health | Public | — | — |
Peer ranks
Portfolio size#16
Portfolio exits#13
Raises, 12 months#12
Co-investors#3
Co-investors
- RA CapitalVenture capital5 shared
- Andreessen HorowitzVenture capital4 shared
- Third Rock VenturesVenture capital4 shared
- ARCH VentureVenture capital3 shared
- Boxer CapitalVenture capital3 shared
- Deerfield Capital ManagementVenture capital3 shared
- Foresite CapitalVenture capital3 shared
- Perceptive AdvisorsVenture capital3 shared
- Perceptive Life SciencesVenture capital3 shared
- Redmile GroupVenture capital3 shared
Sectors
- Biotech15
- Medtech2
- Digital health1
- Quantum1
- Clean tech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.